Transmission of MRSA between Companion Animals and Infected Human Patients Presenting to Outpatient Medical Care Facilities by Ferreira, Jorge Pinto et al.
Transmission of MRSA between Companion Animals and
Infected Human Patients Presenting to Outpatient
Medical Care Facilities
Jorge Pinto Ferreira
1,2*, Kevin L. Anderson
1, Maria T. Correa
1, Roberta Lyman
1, Felicia Ruffin
2, L. Barth
Reller
2, Vance G. Fowler Jr.
2
1Department of Population Health and Pathobiology (PHP), North Carolina State University (NCSU) College of Veterinary Medicine, Raleigh, North Carolina, United States
of America, 2Department of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, United States of America
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen in both human and veterinary medicine. The
importance of companion animals as reservoirs of human infections is currently unknown. The companion animals of 49
MRSA-infected outpatients (cases) were screened for MRSA carriage, and their bacterial isolates were compared with those
of the infected patients using Pulsed-Field Gel Electrophoresis (PFGE). Rates of MRSA among the companion animals of
MRSA-infected patients were compared to rates of MRSA among companion animals of pet guardians attending a
‘‘veterinary wellness clinic’’ (controls). MRSA was isolated from at least one companion animal in 4/49 (8.2%) households of
MRSA-infected outpatients vs. none of the pets of the 50 uninfected human controls. Using PFGE, patient-pets MRSA
isolates were identical for three pairs and discordant for one pair (suggested MRSA inter-specie transmission p-
value=0.1175). These results suggest that companion animals of MRSA-infected patients can be culture-positive for MRSA,
representing a potential source of infection or re-infection for humans. Further studies are required to better understand
the epidemiology of MRSA human-animal inter-specie transmission.
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Introduction
The epidemiology of methicillin-resistant Staphylococcus aureus
(MRSA) is dynamic [1,2]. First identified in the 1960s, MRSA was
initially considered a nosocomial pathogen. Beginning in the late 20
th
century, a specific clone of MRSA, known as USA300, emerged as a
leading cause of community-acquired infection [3–5]. Recently,
another strain of MRSA, Sequence Type 398 (ST-398), has been
shown to be strongly associated with livestock [6], accounting for up
to 20% of all human cases of MRSA infection in the Netherlands [7].
During this time, a growing number of reports have described
probable transmission of S. aureus and MRSA, in particular,
between humans and companion animals [8–13]. Little is known,
however, about the potential role of companion animals in the
transmission of MRSA to humans. For example our understand-
ing regarding direction of transmission, persistence of colonization,
rate of animal-human transmission, inter-specie transmission risk
factors, animal population or breeds with increased risk to be
carriers of MRSA and the significance of companion animals as
reservoirs for human MRSA infections are all incomplete.
In the current study, we sought to investigate the significance of
pets/companion animals as sources of MRSA infection or re-
infection for human outpatients by evaluating MRSA transmission
between MRSA-infected outpatients and their companion ani-
mals. Our results suggest that this reservoir might be more
significant than currently considered.
Materials and Methods
Ethics Statement
This cross-sectional study was a collaboration between Duke
University School of Medicine and North Carolina State
University College of Veterinary Medicine and was approved by
Institutional Review Boards (CR1_Pro00018484; 1417-10) and
Animal Care and Use Committees ( A-329-09-11; 10-054-B) at
both participating institutions.
Ascertainment of Cases and Control Groups
Between January and May 2010, MRSA-positive patients seen
as outpatients at a large southeastern United States hospital were
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older, ability to speak in English and residence within a 50 miles
radius from the hospital. The health care providers of the patients
meeting these criteria were contacted by study personnel to obtain
permission to contact the individuals. If the health care provider
consented, patients were contacted by phone to determine if they
had companion animals. If patients lived with companion animals
and consented (in written form) to participate in the study, a
household visit was scheduled to obtain nasal swabs from the
animals to determine their MRSA status. A short questionnaire
was given to the animal guardians on the day of the visit. The goal
of this questionnaire was to identify inter-specie transmission risk
factors. Forty nine patients, 76 dogs, 25 cats and3 hamsters were
included in the study population. Thirteen adult (older than
eighteen) family members (of the 49 human cases) voluntarily
participated in this study, answering the questionnaire and self-
collecting nasal swabs to determine their MRSA status.
Companion animals presenting to a veterinary institution
wellness clinic and their guardians served as a control population.
Animals were voluntarily taken to this clinic mainly for prophylactic
vaccinations, being otherwise generally healthy. The control
population included 50 people and 45 dogs and 30 cats.
We used contingency tables to assess the associations between
case/control status and the exposure/demographic variables.
Counts, percentages and odds ratios were calculated to quantitate
the strengths of these associations and the statistical significance
was determined with Fisher’s exact test. Statistical analysis was
performed with SAS 9.2 (SAS Institute, Cary, NC, USA).
Microbiological identification of MRSA isolates
The clinical human MRSA isolates from the patients were
collected from the Clinical Microbiology Laboratory of the
medical school integrated in this project and stored (280uC) until
required for additional use.
Staphylococcus spp. identification was performed in accordance with
routine laboratory techniques, including typical colony morphology,
gram stain, catalase and coagulasetests. S. aureus and S. pseudintermedius
diagnosis was confirmed by multiplex PCR [14]. Resistance to
oxacillin and cefoxitin was determined using standard disk diffusion
[15]. S. aureus isolates were classified as MRSA if the inhibition zone
w a sl e s st h a no re q u a lt o2 1m mf o rc e f o x i t i no rl e s st h a no re q u a lt o
10 mm for oxacillin [15]. Oxacillin was used to determine
susceptibility of the S. pseudintermedius isolates. When the inhibition
zone was less than or equal to 17 mm, they were considered resistant.
mecA PCR was performed on the human and animal MRSA
isolates [16].
Genetic relatedness was evaluated by use of pulsed field gel
electrophoresis (PFGE) and spa typing, as previously described [17,18].
Results
A total of 49 MRSA-infected outpatients (cases) and 50
uninfected (human) controls participated in the study. The animal
case population was larger than the control population (total of
107 vs 75 animals) and included more dogs than the animal
control population (76 vs. 45).
Four out of the 49 (8.2%) human cases with culture-confirmed
MRSA infections lived with a companion animal (2 dogs, 1 cat, 1
hamster) from which MRSA was isolated. One of the patients
diagnosed with MRSA lived with a methicillin-resistant Staphylo-
coccus pseudintermedius (MRSP) positive dog.
No MRSA or MRSP was found in the 13 family members of the
MRSA-infected patients that voluntarily participated in this study,
or in the 50 humans or 75 animals of the control population.
Using PFGE, three of the human-animal MRSA pairs were
identical and one was discordant (figure 1). Three of the four
human-animal MRSA isolates pairs were classified as spa type 2
and clonal complex 5 (table 1).
Table 2 presents the results of the univariable analysis (based on
the questionnaire answers) of the variables potentially associated
with MRSA carriage and human-animal transmission. The ones
that were significantly different between cases and controls are
highlighted.
Discussion
Our results provide further evidence into the potential
significance of companion animals as a source of infection and/
or re-infection of humans/outpatients. These findings are
particularly important, as MRSA is the most common identifiable
cause of soft tissue infection in the US [3] and it is estimated that
about 75 million dogs and 88 million cats are owned in the US
[19]. Because companion animals are increasingly seen and
treated as family members by their guardians [20], the opportunity
for transmission between humans and pets is only likely to
increase. Our results are consistent with previous reports. Weese
et al. (2006) studied the transmission of MRSA in veterinary clinics
and in the households, after the identification of a MRSA positive
animal. These authors described 6 cases. MRSA was isolated from
16% (14/88) of household contacts or veterinary personnel and in
all of the 6 cases it was possible to find at least one human isolate
identical to the animal (initial) one [21]. More recently, Faires et al.
evaluated both the rate of MRSA transmission from infected
animals to humans and vice-versa. When the MRSA-infected
animal was initially identified, at least one MRSA-colonized
person was identified in over one-quarter (6/22; 27.3%) of the
study households. By contrast, only one of the 8 (12.5%) study
households of MRSA-infected humans contained a MRSA-
colonized pet [22]. By evaluating about 5 times the number of
MRSA-infected humans as Faires et al. and finding a similar
companion animal MRSA colonization rate (,8%), the current
study externally validates the findings of the previous study. Our
results clearly demonstrate that MRSA transmission between
infected patients and companion animals occurs. Such transmis-
sion between humans and animals has been previously implicated
as potential cause of recurrent MRSA infections [8–13]. Previous
publications have described cases where human MRSA could not
be linked with traditional MRSA sources in the community or
health care facilities [23]. This challenges the accepted epidemi-
ology of MRSA and suggests that there are currently unrecog-
nized/unknown sources of MRSA. Finding 5 out of 8 (62.5%)
MRSA isolates that were not identical to any of the most common
(and previously described by the Centers for Disease Control
(CDC)) Hospital Acquired (HA) or Community Acquired (CA)
MRSA clones seems to reinforce this idea.
Not finding MRSA in any of the humans or animals of the
control population was surprising. Veterinarians have been
described as a professional group with increased risk of carrying
MRSA [7,24]. Different prevalence studies have found very
diverse prevalence values in small/companion animals [25–28].
To our knowledge, prevalence in companion animals has never
been determined in North Carolina, which makes it hard to
evaluate the absence of MRSA in the animal control population.
Our study has limitations. Finding MRSA in both outpatients
and their companion animals is suggestive of inter species
transmission of this agent. However, we can only speculate about
transmission and there is the possibility that both parts became
infected from different sources. Direction of transmission also
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MRSA pairs is not statistically significant (p=0.1175) consid-
ering a reasonable significance level and therefore a larger
sample size should be considered in future studies. The most
ideal control population would have been the one formed by
outpatients diagnosed with methicillin sensitive Staphylococcus
aureus (MSSA) living with companion animals, with the same
number of both humans and animals in the study and control
populations (a 1:1 ratio). Using the population of animals and
their guardians that attended a wellness clinic was, therefore, a
convenient, involving less costs and more readily available
choice. We still believe, however, that this gave us an estimate of
the prevalence of MRSA co-existence at the household level in
healthy humans and animals in the general population. The
average time between a MRSA outpatient identification
(control) and sampling/swabbing of its companion animals
was approximately one month, so there is a possibility that some
colonized animals were missed [22].
Other Staphylococcus spp. trans-infection
The primary goal of this project was to study human-animal
MRSA transmission. Increased attention has, at the same time,
been given by the scientific community to other Staphylococcus
species (spp.) inter-specie transmission [29–32]. More recently, a
novel staphylococcus has been identified: Staphylococcus pseudinter-
medius [33]. Since S. pseudintermedius is coagulase positive, the
possibility of misdiagnosis in clinical microbiology laboratories is
possible and has to be taken into consideration [31,34]. Our
finding of a human infected with MRSA living with an MRSP
animal should be investigated in future projects. The exchange of
genetic material between different species of staphylococci has
been repeatedly reported and emphasized [32,35,36] and its
significance for human infections is currently unknown.
Challenges and future research
One of the most challenging aspects of this project was the
enrollment of patients. Of the 557 patients diagnosed with MRSA
during our study at the medical school hospital integrated in this
project, 231 would match our inclusion criteria and only 49 were
enrolled (response rate of approximately 21% (49/231)).Reasons
for this included: difficulty in reaching the health care providers
and patients, the non-existence of companion animals in the
household, residences being outside the 50 mile radius, the
inexistence of financial compensation to the participants, and
patient or medical team declining participation.
Future research should focus on the dynamics of transmission.
Longitudinal studies with multiple samplings of animals and
humans will be critical in addressing questions regarding direction
of transmission and duration of colonization. Obtaining an IRB
permission for the enrollment and sampling of children would be
important, as MRSA is known to be more prevalent in younger
kids [37]. Environmental samples should also be taken at the
household level to identify other potential sources of reinfection.
Staphylococcus diagnostic protocols should be carefully reviewed
to make sure that the recently discovered coagulase positive
staphylococci are included in the differential diagnosis list.
Staphylococci should be characterized at the molecular level with
different techniques (PFGE, multiplex PCR, multi locus sequence
typing, spa typing) to allow a better comparison with different
studies and traceability of the isolates origin.
Figure 1. PFGE comparison of human and animal MRSA pairs.
doi:10.1371/journal.pone.0026978.g001
Table 1. Summary of the classification of the MRSA isolates, using spa typing.
patient : animal pair CDC classification spa typing clonal complex Pair similarity Specific risk factor(s)
patient 533
cat 533
USA 100
USA 100
type 2
type 2
cc 5
cc 5
identical patient was cancer survivor and had been
hospitalized in the previous year; animal was
allowed to move freely in house
patient 547
dog 547
USA 300
not a common CDC-designated
isolate
type 1
type176
cc 8
cc 5
Non identical patient had been hospitalized in the
previous year and animal was allowed to
move freely in the house
patient 598
hamster 598
not a common
CDC-designated isolate
not a common
CDC-designated isolate
type 2
type 2
cc 5
cc 5
identical patient with diabetes, organ transplant, renal
insufficiency and depression that had been
hospitalized in the previous year; animal with
open sores
patient 609
dog 609
not a common
CDC-designated isolate
not a common
CDC-designated isolate
type 2
type 2
cc 5
cc 5
identical patient was a healthcare worker and animal
was allowed to move freely in the house
doi:10.1371/journal.pone.0026978.t001
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Variable
Cases
(n ; %)
Controls
(n ; %) OR 95% CI
Do you have a FM who is HCW?
Yes 7 (14.28%) 17 (34%)
No 42 (85.71%) 33 (66%) 0.32 [0.12, 0.87]
Do you have a FM who is a veterinarian?
Yes 1 (2.27%) 9 (18%)
No 43 (97.72%) 41 (82%) 0.11 [0.01, 0.87]
Are there children in the household?
Yes 22 (44.9%) 8 (16%)
No 27 (55.1%) 42 (84%) 4.28 [1.67, 10.98]
Has a FM been treated with AB in the past year?
Yes 22 (44.9%) 14 (29.79%)
No 27 (55.1%) 33 (70.21%) 1.92 [0.83, 4.45]
Has a FM been diagnosed with MRSA in the past year?
Yes 8 (16.33%) 1(2.04%)
No 41 (83.67%) 48 (97.96%) 9.37 [1.12, 78.05]
Were you hospitalized in the past year?
Yes 15 (31.25%) 4 (8%)
No 33 (68.75%) 46 (92%) 5.23 [1.59, 17.18]
Have you been diagnosed with a disease or take
medication that affects your immune condition?
Yes 28 (57.14%) 3 (6%)
No 21 (42.86%) 47 (94%) 20.89 [5.71, 76.42]
Are you a HCW?
Yes 8 (16.33%) 3 (6%)
No 41 (83.67%) 47 (94%) 3.06 [0.76, 12.29]
Aware of recent (past month) contact with person or animals MRSA
positive?
Yes 7 (14.29%) 5 (10%)
No 42 (85.71%) 45 (90%) 1.5 [0.44, 5.09]
Were you treated with any AB in the past year?
Yes 38 (77.55%) 18 (36%)
No 11 (22.45%) 32 (64%) 6.14 [2.53, 14.89]
Do any of your animals have current sores?
Yes 7 (14.28%) 6 (12%)
No 42 (85.71%) 44 (88%) 1.22 [0.34, 3.51]
Were any of your animals hospitalized in the past year?
Yes 5 (10.20%) 6 (12%)
No 44 (89.80%) 44 (88%) 0.83 [0.26, 3.25]
Are any of your animals allowed to go outdoors?
Yes 24 (48.98%) 11 (22%)
No 25 (51.02%) 39 (78%) 3.4 [0.71, 4.07]
Are any of your animals allowed to move freely in the house?
Yes 36 (74%) 46 (92%)
No 13 (26%) 4 (8%) 0.24 [0.16, 1.79]
Are any of the animals allowed to lick human faces?
Yes 21 (42.86%) 37 (74%)
No 28 (57.14%) 13 (26%) 0.26 [0.24, 1.31]
Are any of the animals allowed to sleep where humans sleep?
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Nearly 8% of MRSA outpatients lived with a MRSA pet. When
faced with chronic and or recurrent MRSA cases, physicians
should consider the possibility of household pets as MRSA source.
Patients should be informed of this possibility. Unnecessary close
contact should be avoided and heightened hygiene practices
should be instituted. Sampling/swabbing of all the human and
animals in a household seems appropriate to identify unrecognized
sources and break potential cycles of reinfection especially in cases
involving immunocompromised patients. It is critical that medical
and veterinary institutions partner and collaborate in researching
this topic. The legal/institutional approval that regulates this type
of partnerships should be expedited to encourage them. MRSA
epidemiology is a perfect example of an infectious disease agent
whose control requires a ‘‘One Health’’ approach.
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